SuperworthElectromed profit margin ELMD
Gross, operating and net profit as a share of revenue over the last twelve months, from 2011.
- Net margin, 12 months
- 15.3%
- Operating margin, 12 months
- 18.8%
- Net margin on a year earlier
- +3.5 pts
- Peer median
- 5.4%
Over the twelve months to Jun 30, 2026, Electromed kept 15.3% of its revenue as net profit, with an operating margin of 18.8% and a gross margin of 78.5%.
Five years earlier its net margin was 6.6%.
The median for 10 healthcare stocks of a similar size is 5.4%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2026 | 15.3% | 18.8% | 78.5% |
| FY2025 | 11.8% | 15.1% | 78.1% |
| FY2024 | 9.4% | 12.0% | 76.3% |
| FY2023 | 6.6% | 8.3% | 76.0% |
| FY2022 | 5.5% | 7.1% | 75.5% |
| FY2021 | 6.6% | 8.8% | 76.4% |
| FY2020 | 12.8% | 15.8% | 77.6% |
| FY2019 | 6.3% | 9.0% | 76.2% |
| FY2018 | 6.5% | 9.6% | 76.9% |
| FY2017 | 8.6% | 13.8% | 79.5% |
| FY2016 | 9.6% | 13.5% | 77.7% |
| FY2015 | 5.6% | 6.8% | 70.1% |
| FY2014 | −8.3% | −4.8% | 68.7% |
| FY2013 | −8.8% | −12.1% | 69.2% |
| FY2012 | 1.0% | 3.1% | 72.4% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q4 FY26 | 15.3% | +3.5 pts | 18.8% | |
| Q3 FY26 | 14.1% | +2.4 pts | 18.3% | |
| Q2 FY26 | 13.1% | +1.7 pts | 16.7% | |
| Q1 FY26 | 12.4% | +1.0 pts | 15.7% | |
| Q4 FY25 | 11.8% | +2.4 pts | 15.1% | |
| Q3 FY25 | 11.7% | +3.5 pts | 14.6% | |
| Q2 FY25 | 11.3% | +3.7 pts | 14.5% | |
| Q1 FY25 | 11.3% | +4.8 pts | 14.7% | |
| Q4 FY24 | 9.4% | +2.8 pts | 12.0% | |
| Q3 FY24 | 8.1% | +2.6 pts | 10.7% | |
| Q2 FY24 | 7.6% | +2.9 pts | 9.9% | |
| Q1 FY24 | 6.5% | +1.9 pts | 8.3% |
Against its peers
Companies in Healthcare nearest Electromed's size, closest first, today.
| Company | Profit margin |
|---|---|
| ELMDElectromed | 15.3% |
| NATRNatures Sunshine Products | 3.7% |
| UTMDUtah Medical Products | 29.0% |
| PLXProtalix BioTherapeutics | 23.5% |
| PDEXPro DEX | 17.6% |
| INFUInfuSystem | 6.0% |
| VMDViemed Healthcare | 4.8% |
| EMBCEmbecta | 8.6% |
| ARVNArvinas | 2.9% |
| NRCNRC Health | 4.2% |
| KEQUKewaunee Scientific | 3.0% |
| Peer median | 5.4% |
Where Electromed ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Electromed
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.